1. Solomon B, Parihar N, Ayodele L, Hughes M (2017). Global incidence and prevalence of acute lymphoblastic leukemia: 10 years forecast. J Blood Disord Transfus 8:5 (suppl)
2. Katz AJ, Chia VM, Schoonen WM, Kelsh MA (2015) Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden. Cancer Causes Control 26(11):1627–1642. https://doi.org/10.1007/s10552-015-0657-6
3. Rowe JM (2010) Prognostic significance in adult acute lymphoblastic leukemia. Br J Haematol 150:389–405
4. Ruiz RD, Lopez LA, Ruiz AV, Garcés-Ruiz O, Nava-Zavala A, Rubio-Jurado B (2015) Analysis of clinical-biological features of adult acute lymphoblastic leukemia(ALL). Gac Med Mex 151:136–144
5. Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM, Lazarus HM, Franklin IM, Litzow MR, Ciobanu N, Prentice HG, Durrant J, Tallman MS, Goldstone AH (2005) Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALLXII/ECOG E2993. Blood 106(12):3760–3767